T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
STAAR Surgical
STAA
$1.28B
| $1.63M | ﹤0.01% |
23,033
-626
| -3% | -$53.6K |
|
1527
Kirby Corp
KEX
$7.28B
| $1.62M | ﹤0.01% |
26,667
+5,188
| +24% | +$332K |
|
|
MEKA
1528
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $1.62M | ﹤0.01% |
163,738
-34,200
| -17% | -$340K |
|
1529
GATX Corp
GATX
$6.35B
| $1.6M | ﹤0.01% |
18,826
+2,789
| +17% | +$269K |
|
1530
Oceaneering
OII
$5.18B
| $1.6M | ﹤0.01% |
201,298
-785
| -0.4% | -$7.38K |
|
|
JHG
1531
DELISTED
Janus Henderson
JHG
| $1.6M | ﹤0.01% |
78,834
+11,609
| +17% | +$281K |
|
|
SJI
1532
DELISTED
South Jersey Industries, Inc.
SJI
| $1.6M | ﹤0.01% |
47,856
-13,202
| -22% | -$450K |
|
1533
Plexus
PLXS
$7.09B
| $1.59M | ﹤0.01% |
18,173
+1,792
| +11% | +$160K |
|
1534
Renasant Corp
RNST
$3.97B
| $1.59M | ﹤0.01% |
50,858
+3,162
| +7% | +$103K |
|
1535
Glaukos
GKOS
$11B
| $1.59M | ﹤0.01% |
29,808
+3,917
| +15% | +$202K |
|
|
WIRE
1536
DELISTED
Encore Wire Corp
WIRE
| $1.59M | ﹤0.01% |
13,723
+8,307
| +153% | +$1.01M |
|
1537
Park National Corp
PRK
$3.75B
| $1.59M | ﹤0.01% |
12,737
-1,880
| -13% | -$243K |
|
1538
Matthews International
MATW
$724M
| $1.58M | ﹤0.01% |
70,391
+2,694
| +4% | +$70.1K |
|
|
DOC
1539
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.57M | ﹤0.01% |
104,537
+17,449
| +20% | +$295K |
|
1540
iShares Russell 1000 Value ETF
IWD
$84.2B
| $1.57M | ﹤0.01% |
11,551
| – | – |
|
1541
PENN Entertainment
PENN
$2.52B
| $1.57M | ﹤0.01% |
57,099
-162,944
| -74% | -$5.26M |
|
|
CVET
1542
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.57M | ﹤0.01% |
75,142
-1,822,959
| -96% | -$38M |
|
1543
Check Point Software Technologies
CHKP
$13.5B
| $1.57M | ﹤0.01% |
13,974
-100
| -0.7% | -$12.1K |
|
1544
Blackstone Mortgage Trust
BXMT
$2.43B
| $1.56M | ﹤0.01% |
66,730
+12,380
| +23% | +$359K |
|
1545
O-I Glass
OI
$1.03B
| $1.56M | ﹤0.01% |
120,113
-15,759
| -12% | -$213K |
|
1546
ESCO Technologies
ESE
$7.92B
| $1.55M | ﹤0.01% |
21,104
-2,726,266
| -99% | -$212M |
|
1547
Unifirst Corp
UNF
$5.2B
| $1.54M | ﹤0.01% |
9,173
+1,452
| +19% | +$265K |
|
1548
Brady Corp
BRC
$4.43B
| $1.54M | ﹤0.01% |
36,926
-1,972,695
| -98% | -$91M |
|
1549
Independent Bank
INDB
$4.06B
| $1.53M | ﹤0.01% |
20,549
-1,594,063
| -99% | -$129M |
|
1550
OFG Bancorp
OFG
$2.25B
| $1.53M | ﹤0.01% |
60,770
+32,625
| +116% | +$885K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.